Evidence map›Paper›PMID 19282480›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2009

Synthesis of programmable integrases.

Russell M Gordley, Charles A Gersbach, Carlos F Barbas

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 91 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. The Development of TALE Nucleases for Biotechnology.Methods in molecular biology (Clifton, N.J.) · 2016
    Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Russell M GordleyDepartments of Molecular Biology and Chemistry and The Skaggs Institute for Chemical Biology, BCC 550, The Scripps Research Institute, La Jolla, CA 92037, USA.
Charles A Gersbach
Carlos F Barbas
Scripps Research Institute · US

Funding

Zinc Finger Recombinases for Endogenous Genome TailoringR21CA126664 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI BARBAS, CARLOS F · 2008 to 2009
$461k
Regulating Sensitivity to Cancer Therapy with Engineered Transcription FactorsF32CA125910 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI GERSBACH, CHARLES A. · 2007 to 2009
$113k
NCI NIH HHS F32 CA125910NCI NIH HHS R21 CA126664NCI NIH HHS R21CA126664
6 · The paper itself

Abstract

Accurate modification of the 3 billion-base-pair human genome requires tools with exceptional sequence specificity. Here, we describe a general strategy for the design of enzymes that target a single site within the genome. We generated chimeric zinc finger recombinases with cooperative DNA-binding and catalytic specificities that integrate transgenes with >98% accuracy into the human genome. These modular recombinases can be reprogrammed: New combinations of zinc finger domains and serine recombinase catalytic domains generate novel enzymes with distinct substrate sequence specificities. Because of their accuracy and versatility, the recombinases/integrases reported in this work are suitable for a wide variety of applications in biological research, medicine, and biotechnology where accurate delivery of DNA is desired.

Indexed as

Genome, HumanBinding SitesCatalytic DomainDNA-Binding ProteinsGene Knock-In TechniquesGene TargetingHumansIntegrasesProtein EngineeringRecombinant Fusion ProteinsRecombinasesSubstrate SpecificityTransgenesZinc FingersDNA-Binding ProteinsIntegrasesRecombinant Fusion ProteinsRecombinases

Identifiers

PMID19282480
PMCPMC2654808
OpenAlexW2070055731

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.